If someone told you that you might have a second chance at life, you wouldn’t say no, would you?
Now, US firm Bioquark plans to test a new stem-cell treatment on deceased patients in South America.
According to CEO Ira Pastor, Bioquark has developed a series of injections that can restart the brain – and trials could be carried out as early as this year.
Plans to conduct trials in India last year were scratched by the Indian Council of Medical Research.
The process is a three-stage procedure:
First, researchers inject stems cells from the patient’s own blood back into their body.
They then inject peptides into the patient’s spinal cord.
Lastly, the patient undergoes a two-week course of median nerve stimulation to try and reverse brain death while under observation via MRI scans.
The trials are part of a broader project called ReAnima.
“The Mission of the ReAnima Project is to focus on clinical research in the state of brain death, or irreversible coma, in subjects who have recently met the Uniform Determination of Death Act Criteria, but who are still on card-pulmonary or trophic support – a classification in many countries around the world known as a ‘living cadaver’”, Pastor says.
Rather feel alive and well now rather than relying on “Frankenscience”? Check out the 13 reasons to remember life is good.
